| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/23/2006 | WO2003083085A3 Transporters and ion channels |
| 03/23/2006 | WO2003075855A3 Antibodies against cancer antigen tmeff2 and uses thereof |
| 03/23/2006 | WO2003049602A3 Diagnostic methods for protein profiling |
| 03/23/2006 | US20060064781 Glycoengineered immunoglobulin comprising Fc region containing N-linked oligosaccharides for use in targeted destruction of tumor tissues |
| 03/23/2006 | US20060063923 4-1BB peptides and methods for use |
| 03/23/2006 | US20060063922 Epidermal differentiation factor |
| 03/23/2006 | US20060063921 Ligand |
| 03/23/2006 | US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/23/2006 | US20060063728 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/23/2006 | US20060063715 Multivalent antigen-binding proteins |
| 03/23/2006 | US20060063254 Antibody composition-producing cell |
| 03/23/2006 | US20060063249 Human cathepsin |
| 03/23/2006 | US20060063247 Increased thermostability, photostability, and water solubility |
| 03/23/2006 | US20060063235 DNA encoding the human serine protease C-E |
| 03/23/2006 | US20060063234 Efficient production of IgM in recombinant mammalian cells |
| 03/23/2006 | US20060063228 Antibodies against human interleukin-13 and uses therefor |
| 03/23/2006 | US20060063209 Engineered antibody fragment that irreversibly binds an antigen |
| 03/23/2006 | US20060063201 Crystals of the Fc region of immunoglobulin epsilon heavy chain protein |
| 03/23/2006 | US20060063200 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/23/2006 | US20060063172 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample |
| 03/23/2006 | US20060063167 DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 03/23/2006 | US20060063152 Novel gene and protein encoded by the gene |
| 03/23/2006 | US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 03/23/2006 | US20060062800 Immunogens; envelope proteins; kits |
| 03/23/2006 | US20060062799 Sperm specific lysozyme-like proteins |
| 03/23/2006 | US20060062798 Vaccines |
| 03/23/2006 | US20060062796 Polysaccharide-polypeptide conjugate |
| 03/23/2006 | US20060062795 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 03/23/2006 | US20060062794 Composition containing particle surface charge control agent, particle separating method using same, particle separator |
| 03/23/2006 | US20060062793 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 03/23/2006 | US20060062792 Novel human p53 splice variant displaying differential transcriptional activity |
| 03/23/2006 | US20060062790 AKT3 inhibitors |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062788 Method for determining MIF content |
| 03/23/2006 | US20060062786 Antibodies that immunospecifically bind to TRAIL receptors |
| 03/23/2006 | US20060062785 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia |
| 03/23/2006 | US20060062784 Compositions monovalent for CD40L binding and methods of use |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062781 Specific ab1'-antibodies against tumour-associated antigen ca 125 |
| 03/23/2006 | US20060062780 Myelin oligodendrocyte glycoprotein; 1st domain: deimmunized, autoreactive antigen specifically recognized by Ig receptors of autoreactive B-cells; 2nd domain: effector molecule capable of interacting with or activating NK-cells, T-cells, macrophages, monocytes or granulocytes; autoimmune diseases |
| 03/23/2006 | US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9) |
| 03/23/2006 | US20060062727 Compositions and methods for the diagnosis and treatment of tumor |
| 03/23/2006 | DE102004037234A1 Verfahren zur Isolierung und Kultivierung von Stammzellen A process for the isolation and culture of stem cells |
| 03/23/2006 | CA2581017A1 Compositions monovalent for cd40l binding and methods of use |
| 03/23/2006 | CA2580362A1 Protective anti-glucan antibodies with preference for .beta.-1,3-glucans |
| 03/23/2006 | CA2580319A1 Vaccine |
| 03/23/2006 | CA2580140A1 Anti-ox40l antibodies |
| 03/23/2006 | CA2579900A1 Cancerous disease modifying antibodies |
| 03/23/2006 | CA2579141A1 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/23/2006 | CA2578131A1 Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates |
| 03/23/2006 | CA2577133A1 Polypeptide variants with altered effector function |
| 03/23/2006 | CA2576940A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2006 | CA2572632A1 Busulfan immunoassay |
| 03/22/2006 | EP1637607A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 03/22/2006 | EP1637601A2 Proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2006 | EP1637598A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 03/22/2006 | EP1637591A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoc |
| 03/22/2006 | EP1637166A2 Virus-like particles for the induction of autoantibodies |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637159A1 Immunocompetent cell activation inhibitor and use thereof |
| 03/22/2006 | EP1637156A1 Systemic administration of osteogenic proteins in the treatment of metabolic bone diseases |
| 03/22/2006 | EP1637146A2 Ex vivo treatment of allogeneic and xenogeneic T-cells with gp39 antagonists |
| 03/22/2006 | EP1636594A2 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs |
| 03/22/2006 | EP1636592A1 Use of prion conversion modulating agents |
| 03/22/2006 | EP1636587A1 Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein |
| 03/22/2006 | EP1636561A2 Combinatorial protein library screening by periplasmic expression |
| 03/22/2006 | EP1636360A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 03/22/2006 | EP1636354A2 Erk7 and erk8, novel diagnostic markers for cancer |
| 03/22/2006 | EP1636334A2 Recombinant anti-cd30 antibodies and uses thereof |
| 03/22/2006 | EP1636270A2 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 03/22/2006 | EP1636269A2 Extracellular aspergillus polypeptides |
| 03/22/2006 | EP1636268A2 Humanized antibodies that recognize beta amyloid peptide |
| 03/22/2006 | EP1636265A2 Binding molecules for the treatment of myeloid cell malignancies |
| 03/22/2006 | EP1636264A2 Tumour necrosis factor receptor molecules with reduced immunogenicity |
| 03/22/2006 | EP1636254A2 Replikin peptides and uses thereof |
| 03/22/2006 | EP1635872A2 Antibodies and fusion proteins that include engineered constant regions |
| 03/22/2006 | EP1635871A2 Methods and compositions for treating rheumatoid arthritis |
| 03/22/2006 | EP1635870A2 Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
| 03/22/2006 | EP1635869A1 Cancerous disease modifying antibodies |
| 03/22/2006 | EP1635868A1 Methods for treating cancer using an immunotoxin |
| 03/22/2006 | EP1635692A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 03/22/2006 | EP1550460A4 Method for correcting immune responses and medicinal agent |
| 03/22/2006 | EP1546360A4 Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 03/22/2006 | EP1545611A4 Method of treatment of asthma using antibodies to complement component c5 |
| 03/22/2006 | EP1513553A4 Methods and materials for treating inflammatory conditions |
| 03/22/2006 | EP1497415A4 Cytokine receptor |
| 03/22/2006 | EP1297016B1 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1008603B1 Soluble polypeptides consisting on the first coiled coil domain of human and mouse epimorphin. |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0951297B1 Detection of antigens via oligonucleotide antibody conjugates |
| 03/22/2006 | EP0948356B1 Agent for identifying and treating metastasizing tumours |
| 03/22/2006 | EP0694044B1 Method and product for regulating cell responsiveness to external signals |
| 03/22/2006 | CN1751236A Transgenic mice expressing human CD20 |
| 03/22/2006 | CN1750844A Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 03/22/2006 | CN1750843A Methods and compositions for inducing apoptosis in cancer cells |
| 03/22/2006 | CN1749273A Human new protein hCRISP56 and its code sequence |
| 03/22/2006 | CN1749272A Human new protein hBTBD56 and its code sequence |
| 03/22/2006 | CN1749271A Human new protein Hunsp 18 and its code sequence |
| 03/22/2006 | CN1246457C Human TSC403 gene and human ING1L gene |